Deep Medicine Acquisition Corp. Appoints John Chiang Director

New York, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) — Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) announced today the appointment of Mr. John Chiang as a member to its board of directors, effective October 15, 2022.

Mr. Chiang has been serving as a member of the board of directors of Apollo Medical Holdings, Inc. since January 2019 and on the corporate advisory boards of Pasadena Private Lending, LLC since February 2019, Adept Urban since January 2021, and Calyx Peak Companies since February 2019. From January 2015 to January 2019, Mr. Chiang served as the California State Treasurer, where he oversaw financial transactions, investments and the sale of bonds. Prior to that, Mr. Chiang served as California State Controller from January 2007 to January 2015.

Humphrey Polanen, Chairman of the board of directors and the Company’s Chief Executive Officer, on behalf of the board of directors and management, said, “The DMAQ board of directors is delighted that John has chosen to contribute his expertise and wide ranging experience as a statewide elected official to our company. As a former State of California Controller and Treasurer, John Chiang has a unique background that will strengthen our board.”

About Deep Medicine Acquisition Corp.

DMAQ is a special purpose acquisition company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. DMAQ began trading on the Nasdaq in October 2021, and its common stock and rights are traded under the ticker symbols DMAQ and DMAQR, respectively.